ANA MERCEDES CIUREA to Antineoplastic Agents
This is a "connection" page, showing publications ANA MERCEDES CIUREA has written about Antineoplastic Agents.
Connection Strength
0.033
-
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol. 2016 Apr; 50:79-89.
Score: 0.027
-
Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK. Mol Cancer Ther. 2014 Jan; 13(1):221-9.
Score: 0.006